Published in Cancer Weekly, January 26th, 2010
"In this work, we used an in vitro murine melanoma model that uses a cellular adhesion blockade as a transforming factor to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-01-26)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.